@agiletortoise @rmondello According to my last couple of PCPs, there are carriers who will cover them, but it's definitely the exception.
I also have to acknowledge that doctors are usually fairly far removed from insurance coverage questions.
@agiletortoise @aleen @rmondello This is the correct answer. GLP-1 inhibitors are not weight loss drugs by any technical definition yet. Additionally, they seem to require prior authorization which means your doctor has to apply for you, and that means insurance is keeping a keen eye.
You can find out all specific coverage information, including what therapies are approved and what the requirements are, by searching “<insurer> formulary”.
e.g. here is mine https://blueshieldca.adaptiverx.com/webSearch/index?key=8F02B26A288102C27BAC82D14C006C6FC54D480F80409B68651080F44A11E57C
LOL! Self employed in the US which means I pay through the nose for crappy healthcare to the point I can’t afford extra food to need to lose weight from.
@rmondello I have a little snippet I put together recently in another context, quotes are from the OPM website or carrier letters:
> in 2014, OPM issued Carrier Letter 2014-04 clarifying that it is not permissible to exclude weight loss drugs from FEHB coverage on the basis that obesity is a “lifestyle” condition and not a medical one or that obesity treatment is “cosmetic.”
> In Carrier Letter 2022-03, OPM stated that FEHB Carriers are not allowed to exclude anti-obesity medications from coverage based on a benefit exclusion or a carve out. Carrier Letter 2022-02 outlines the requirements for NonDiscriminatory Formulary Design, namely, that a non-discriminatory formulary design does not have cost or access barriers imposed by disease or condition.
> As new anti-obesity drugs are approved by the FDA, OPM expects Carriers to evaluate and update their coverage of anti-obesity drugs.
The "letters" being referenced are available on the OPM website: https://www.opm.gov/healthcare-insurance/carriers/fehb
AFAIK these letters were issued as a result of union action, but I haven't confirmed that.
@rmondello As a reference, in Switzerland, it can be reimbursed by standard insurance, after a special request by the endocrinologist and as long as it is part of a protocol combining other approaches too (diet, exercise, etc.) in patients whose BMI is "obese" or is "overweight" + diabetes / hypertension /etc.